Monashee Investment Management LLC Nu Cana PLC Transaction History

Monashee Investment Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 09, 2021	SELL	$1.95 - $2.85 $390,000 - $570,000	-200,000 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$2.7 - $5.04 $540,000 - $1.01 Million	200,000 New	200,000 $554,000
Q4 2020 Feb 11, 2021	SELL	$4.4 - $5.59 $1.76 Million - $2.24 Million	-400,000 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$4.57 - $6.48 $1.83 Million - $2.59 Million	400,000 New	400,000 $2.07 Million
Q4 2017 Feb 09, 2018	SELL	$10.0 - $18.72 $2.1 Million - $3.93 Million	-210,000 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$16.15 - $18.37 $3.39 Million - $3.86 Million	210,000	210,000 $3.86 Million

3.33M

Ticker NCNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,196,000
Market Cap $59M
Description
NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. The company develops its products based on its proprietary ProTide technology. Its lead product candidate includes Acelarin, which is in Phase I clinical trial for patients with advanced solid tumors; Phase Ib for patients ...

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Monashee Investment Management LLC with notifications on news.